Literature DB >> 19667070

The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides.

Ruth Geiss-Friedlander1, Nicolas Parmentier, Ulrike Möller, Henning Urlaub, Benoit J Van den Eynde, Frauke Melchior.   

Abstract

Protein degradation is an essential process that continuously takes place in all living cells. Regulated degradation of most cellular proteins is initiated by proteasomes, which produce peptides of varying length. These peptides are rapidly cleaved to single amino acids by cytoplasmic peptidases. Proline-containing peptides pose a specific problem due to structural constrains imposed by the pyrrolidine ring that prevents most peptidases from cleavage. Here we show that DPP9, a poorly characterized cytoplasmic prolyl-peptidase, is rate-limiting for destruction of proline-containing substrates both in cell extracts and in intact cells. We identified the first natural substrate for DPP9, the RU1(34-42) antigenic peptide (VPYGSFKHV). RU1(34-42) is degraded in vitro by DPP9, and down-regulation of DPP9 in intact cells results in increased presentation of this antigen. Together our findings demonstrate an important role for DPP9 in peptide turnover and antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667070      PMCID: PMC2785648          DOI: 10.1074/jbc.M109.041871

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Authors:  S Morel; F Lévy; O Burlet-Schiltz; F Brasseur; M Probst-Kepper; A L Peitrequin; B Monsarrat; R Van Velthoven; J C Cerottini; T Boon; J E Gairin; B J Van den Eynde
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

3.  Two new proteases in the MHC class I processing pathway.

Authors:  L Stoltze; M Schirle; G Schwarz; C Schröter; M W Thompson; L B Hersh; H Kalbacher; S Stevanovic; H G Rammensee; H Schild
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

Review 4.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

5.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

6.  The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases.

Authors:  Frédéric Lévy; Lena Burri; Sandra Morel; Anne-Lise Peitrequin; Nicole Lévy; Angela Bachi; Ulf Hellman; Benoît J Van den Eynde; Catherine Servis
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum.

Authors:  Thomas Serwold; Federico Gonzalez; Jennifer Kim; Richard Jacob; Nilabh Shastri
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

8.  Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

Authors:  D Marguet; L Baggio; T Kobayashi; A M Bernard; M Pierres; P F Nielsen; U Ribel; T Watanabe; D J Drucker; N Wagtmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

9.  Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase.

Authors:  T Saric; J Beninga; C I Graef; T N Akopian; K L Rock; A L Goldberg
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

Review 10.  The prolyl oligopeptidase family.

Authors:  L Polgár
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

View more
  31 in total

1.  The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus.

Authors:  Daniela Justa-Schuch; Ulrike Möller; Ruth Geiss-Friedlander
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

2.  Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer.

Authors:  Breyan Ross; Stephan Krapp; Martin Augustin; Reiner Kierfersauer; Marcelino Arciniega; Ruth Geiss-Friedlander; Robert Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

3.  The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.

Authors:  Esther Pilla; Markus Kilisch; Christof Lenz; Henning Urlaub; Ruth Geiss-Friedlander
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

Review 4.  The expression of proline-specific enzymes in the human lung.

Authors:  Gwendolyn Vliegen; Tom K Raju; Dirk Adriaensen; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Ann Transl Med       Date:  2017-03

Review 5.  Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.

Authors:  Nathalie Vigneron; Benoît J Van den Eynde
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

6.  Induced-fit mechanism for prolyl endopeptidase.

Authors:  Min Li; Changqing Chen; David R Davies; Thang K Chiu
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

7.  A novel SUMO1-specific interacting motif in dipeptidyl peptidase 9 (DPP9) that is important for enzymatic regulation.

Authors:  Esther Pilla; Ulrike Möller; Guido Sauer; Francesca Mattiroli; Frauke Melchior; Ruth Geiss-Friedlander
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

8.  Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.

Authors:  Sumaiya Chowdhury; Yiqian Chen; Tsun-Wen Yao; Katerina Ajami; Xin M Wang; Yury Popov; Detlef Schuppan; Patrick Bertolino; Geoffrey W McCaughan; Denise Mt Yu; Mark D Gorrell
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

9.  Grassypeptolides as natural inhibitors of dipeptidyl peptidase 8 and T-cell activation.

Authors:  Jason C Kwan; Yanxia Liu; Ranjala Ratnayake; Ryo Hatano; Akiko Kuribara; Chiko Morimoto; Kei Ohnuma; Valerie J Paul; Tao Ye; Hendrik Luesch
Journal:  Chembiochem       Date:  2014-03-03       Impact factor: 3.164

Review 10.  Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.

Authors:  L Wagner; C Klemann; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-03-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.